Kidney disease currently affects around 850 million people worldwide and one in ten adults has chronic kidney disease (CKD) which is projected to become the 5th most common cause of life lost globally in 2040

As of September 6th, 2021, WHO reports over 220,563,227 confirmed cases of COVID-19 globally. The risk of a second infection in individuals who have recovered from COVID-19 is a serious threat

The COVID-19 virus, which has infected and killed millions of people, continues to spread around the world. The lives of children and their families around the world have been upended by the COVID-19 epidemic.

AliveDx Suisse S.A. and Bio-State Inc. have signed a distribution agreement, which will enable Bio-State Inc. to distribute the MosaiQ® solution in India. The distribution agreement takes effect immediately. This strategic partnership with an important partner in India reaffirms AliveDx’s commitment to expanding its geographical presence and creating clinical and economical value for clinicians, helping them… Continue reading AliveDx Suisse S.A. and Bio-State Inc. Sign Distribution Agreement in India